Deuterx

Improving racemic small molecule marketed drugs and drug candidates intended for patients across multiple therapeutic indications.

placeAndover, Massachusetts, United States calendar_todayFounded 2012 groups6 employees language deuterx.com

Innovation

19 patent families (13 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,539 times.

YearFilings
20156
201611
20176
201810
20196
20202
20214
20224
20234
20242
20253
20261

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon